Description
SWOT ANALYSIS OF SINOPHARM
Sinopharm
Parent Company
Sinopharm
Category
Pharmaceutical
Sector
Healthcare
Tagline/ Slogan
Caring for life attending to health
USP
It is largest healthcare group in China
STP
Segment
Pharmaceutical manufacturing, research, distribution
Healthcare professionals, retail pharmacies, hospitals & medical Target Group diagnostics groups
Sinopharm is the largest medical and healthcare group that operates in business segments of distribution, retail, R&D and manufacture of Positioning healthcare related products.
SWOT Analysis
1. Strong annual revenue & gross profit 2. Largest pharmaceutical distribution system covering over 31 provinces 3. Company owns first class pharmaceutical manufacturers, medical device manufacturers 4. Total sales revenue increasing consistently 5. It has its global presence in Africa, France, US, Germany and a few Strength other companies
1. Over dependence on Chinese markets which is highly regulated Weakness 2.Limited presence in other Asian countries and the European countries
1. Strong growth rate of china’s pharmaceutical market 2. It can collaborate with other western companies for new technology 3. Extension of medical insurance to greater portion of Chinese Opportunity populations
Threats
1. Many other Chinese companies upgrading their technology & posing
strong challenge 2. Stringent regulatory measures 3. New well established foreign companies entering Chinese markets
Competition
1. Shijiazhuang Pharma Group 2. Wuxi Pharmatech 3. C & O Pharmaceutical Technology Holdings Ltd Competitors 4. Novartis
doc_804250679.docx
SWOT ANALYSIS OF SINOPHARM
Sinopharm
Parent Company
Sinopharm
Category
Pharmaceutical
Sector
Healthcare
Tagline/ Slogan
Caring for life attending to health
USP
It is largest healthcare group in China
STP
Segment
Pharmaceutical manufacturing, research, distribution
Healthcare professionals, retail pharmacies, hospitals & medical Target Group diagnostics groups
Sinopharm is the largest medical and healthcare group that operates in business segments of distribution, retail, R&D and manufacture of Positioning healthcare related products.
SWOT Analysis
1. Strong annual revenue & gross profit 2. Largest pharmaceutical distribution system covering over 31 provinces 3. Company owns first class pharmaceutical manufacturers, medical device manufacturers 4. Total sales revenue increasing consistently 5. It has its global presence in Africa, France, US, Germany and a few Strength other companies
1. Over dependence on Chinese markets which is highly regulated Weakness 2.Limited presence in other Asian countries and the European countries
1. Strong growth rate of china’s pharmaceutical market 2. It can collaborate with other western companies for new technology 3. Extension of medical insurance to greater portion of Chinese Opportunity populations
Threats
1. Many other Chinese companies upgrading their technology & posing
strong challenge 2. Stringent regulatory measures 3. New well established foreign companies entering Chinese markets
Competition
1. Shijiazhuang Pharma Group 2. Wuxi Pharmatech 3. C & O Pharmaceutical Technology Holdings Ltd Competitors 4. Novartis
doc_804250679.docx